Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-21-089393

Options or other derivatives

  • Chief Financial Officer acquired 270,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Shawah Robert G. Chief Financial Officer 2021-06-29 Grant or award · Stock Option +70,000 70,000 D
Shawah Robert G. Chief Financial Officer 2021-07-01 Grant or award · Stock Option +200,000 200,000 D
Loading xslF345X03/tm2121425-2_4seq1.xml…